UB Paderborn / Katalog / Suche / in CDI

Type III secretion system effector proteins: double agents in bacterial disease and plant defense

Annual review of phytopathology, 2004-01, Vol.42 (1), p.385-414

2004

Link zum Volltext

Verfügbarkeit prüfen

The type III (Hrp) secretion pathway of plant pathogenic bacteria: trafficking harpins, Avr proteins, and death

Journal of bacteriology, 1997-09, Vol.179 (18), p.5655-5662

1997

Link zum Volltext

Verfügbarkeit prüfen

GacA, the response regulator of a two-component system, acts as a master regulator in Pseudomonas syringae pv. tomato DC3000 by controlling regulatory RNA, transcriptional activators, and alternate sigma factors

Molecular plant-microbe interactions, 2003-12, Vol.16 (12), p.1106-1117

2003

Link zum Volltext

Verfügbarkeit prüfen

Bacterial pathogens in plants: life up against the wall

The Plant cell, 1996-10, Vol.8 (10), p.1683-1698

1996

Link zum Volltext

Verfügbarkeit prüfen

Proposed guidelines for a unified nomenclature and phylogenetic analysis of type III Hop effector proteins in the plant pathogen Pseudomonas syringae

Molecular plant-microbe interactions, 2005-04, Vol.18 (4), p.275-282

2005

Link zum Volltext

Verfügbarkeit prüfen

Whole-Genome Expression Profiling Defines the HrpL Regulon of Pseudomonas syringae pv. tomato DC3000, Allows de novo Reconstruction of the Hrp cis Clement, and Identifies Novel Coregulated Genes

Molecular plant-microbe interactions, 2006-11, Vol.19 (11), p.1167-1179

2006

Link zum Volltext

Verfügbarkeit prüfen

The Pseudomonas syringae pv. tomato HrpW protein has domains similar to harpins and pectate lyases and can elicit the plant hypersensitive response and bind to pectate

Journal of Bacteriology, 1998-10, Vol.180 (19), p.5211-5217

1998

Link zum Volltext

Verfügbarkeit prüfen

Expression of the Pseudomonas syringae avirulence protein AvrB in plant cells alleviates its dependence on the hypersensitive response and pathogenicity (Hrp) secretion system in eliciting genotype-specific hypersensitive cell death

The Plant cell, 1996-07, Vol.8 (7), p.1095-1105

1996

Link zum Volltext

Verfügbarkeit prüfen

Avr (effector) proteins HrmA (HopPsyA) and AvrPto are secreted in culture from Pseudomonas syringae pathovars via the Hrp (type III) protein secretion system in a temperature- and pH-sensitive manner

Journal of bacteriology, 1999-08, Vol.181 (16), p.4790-4797

1999

Link zum Volltext

Verfügbarkeit prüfen

HopPtoF locus of Pseudomonas syringae pv. tomato DC3000 encodes a type III chaperone and a cognate effector

Molecular plant-microbe interactions, 2004-05, Vol.17 (5), p.447-455

2004

Link zum Volltext

Verfügbarkeit prüfen

Evidence that the Pseudomonas syringae pv. syringae hrp-linked hrmA gene encodes an Avr-like protein that acts in an hrp-dependent manner within tobacco cells

Molecular plant-microbe interactions, 1997-07, Vol.10 (5), p.580-588

1997

Link zum Volltext

Verfügbarkeit prüfen

Isolation and characterization of a gene coding for a novel aspartate aminotransferase from Rhizobium meliloti

Journal of Bacteriology, 1993-07, Vol.175 (13), p.4186-4196

1993

Link zum Volltext

Verfügbarkeit prüfen

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis

Neuromuscular disorders : NMD, 2014-03, Vol.24 (3), p.222-226

2014

Link zum Volltext

Verfügbarkeit prüfen

Le ratio neutrophiles sur lymphocytes : développement et validation externe pour exclure une fistule pancréatique après duodénopancréatectomie céphalique

Journal de chirurgie viscérale, 2022-09, Vol.159 (4), p.S88

2022

Link zum Volltext

Verfügbarkeit prüfen

P.2.10 A shorter timed walking or running test may be sufficient for testing function in Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.751-752

2013

Link zum Volltext

Verfügbarkeit prüfen

Adénocarcinome du pancréas nécessitant une résection vasculaire après chimiothérapie d’induction par Folfirinox : quels sont les critères prédictifs d’une survie inférieure à 1 an ?

Journal de chirurgie viscérale, 2020-09, Vol.157 (3), p.S159-S159

2020

Link zum Volltext

Verfügbarkeit prüfen

T.P.38

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.905-905

2014

Link zum Volltext

Verfügbarkeit prüfen

G.P.112

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.828-829

2014

Link zum Volltext

Verfügbarkeit prüfen

Gene-replacement therapy (GRT) in spinal muscular atrophy type 1 (SMA1): Long-term follow-up from the onasemnogene abeparvovec phase 1/2A clinical trial

Journal of the neurological sciences, 2019-10, Vol.405, p.271-271

2019

Link zum Volltext

Verfügbarkeit prüfen

P.14.16 Longitudinal changes in strength and functional outcomes in sporadic inclusion body myositis

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.818-818

2013

Link zum Volltext

Verfügbarkeit prüfen

P.6.2 Development of a proof-of-concept device using the Microsoft Kinect to assess movement in infants with spinal muscular atrophy

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.770-770

2013

Link zum Volltext

Verfügbarkeit prüfen

P.14.17 Evaluation of the ability of timed walking tests to quantify function in sporadic inclusion body myositis

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.818-818

2013

Link zum Volltext

Verfügbarkeit prüfen

S.P.11 Development of a virtual upper extremity assessment tool for individuals with DMD across the lifespan

Neuromuscular disorders : NMD, 2012-10, Vol.22 (9), p.878-879

2012

Link zum Volltext

Verfügbarkeit prüfen

S.P.3 Diverse walking distances predict functional outcomes in Duchenne Muscular Dystrophy

Neuromuscular disorders : NMD, 2012-10, Vol.22 (9), p.876-876

2012

Link zum Volltext

Verfügbarkeit prüfen

T.P.1

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.860-860

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Type III secretion system effector proteins: double agents in bacterial disease and plant defense

The type III (Hrp) secretion pathway of plant pathogenic bacteria: trafficking harpins, Avr proteins, and death

GacA, the response regulator of a two-component system, acts as a master regulator in Pseudomonas syringae pv. tomato DC3000 by controlling regulatory RNA, transcriptional activators, and alternate sigma factors

Bacterial pathogens in plants: life up against the wall

Proposed guidelines for a unified nomenclature and phylogenetic analysis of type III Hop effector proteins in the plant pathogen Pseudomonas syringae

Whole-Genome Expression Profiling Defines the HrpL Regulon of Pseudomonas syringae pv. tomato DC3000, Allows de novo Reconstruction of the Hrp cis Clement, and Identifies Novel Coregulated Genes

The Pseudomonas syringae pv. tomato HrpW protein has domains similar to harpins and pectate lyases and can elicit the plant hypersensitive response and bind to pectate

Expression of the Pseudomonas syringae avirulence protein AvrB in plant cells alleviates its dependence on the hypersensitive response and pathogenicity (Hrp) secretion system in eliciting genotype-specific hypersensitive cell death

Avr (effector) proteins HrmA (HopPsyA) and AvrPto are secreted in culture from Pseudomonas syringae pathovars via the Hrp (type III) protein secretion system in a temperature- and pH-sensitive manner

HopPtoF locus of Pseudomonas syringae pv. tomato DC3000 encodes a type III chaperone and a cognate effector

Evidence that the Pseudomonas syringae pv. syringae hrp-linked hrmA gene encodes an Avr-like protein that acts in an hrp-dependent manner within tobacco cells

Isolation and characterization of a gene coding for a novel aspartate aminotransferase from Rhizobium meliloti

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis

Le ratio neutrophiles sur lymphocytes : développement et validation externe pour exclure une fistule pancréatique après duodénopancréatectomie céphalique

P.2.10 A shorter timed walking or running test may be sufficient for testing function in Duchenne muscular dystrophy

Adénocarcinome du pancréas nécessitant une résection vasculaire après chimiothérapie d’induction par Folfirinox : quels sont les critères prédictifs d’une survie inférieure à 1 an ?

T.P.38

G.P.112

Gene-replacement therapy (GRT) in spinal muscular atrophy type 1 (SMA1): Long-term follow-up from the onasemnogene abeparvovec phase 1/2A clinical trial

P.14.16 Longitudinal changes in strength and functional outcomes in sporadic inclusion body myositis

P.6.2 Development of a proof-of-concept device using the Microsoft Kinect to assess movement in infants with spinal muscular atrophy

P.14.17 Evaluation of the ability of timed walking tests to quantify function in sporadic inclusion body myositis

S.P.11 Development of a virtual upper extremity assessment tool for individuals with DMD across the lifespan

S.P.3 Diverse walking distances predict functional outcomes in Duchenne Muscular Dystrophy

T.P.1

Suchergebnisse filtern